Literature DB >> 11247546

Matrix metalloproteinases in pathophysiology and treatment of heart failure.

A M Feldman1, Y Y Li, C F McTiernan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11247546     DOI： 10.1016/s0140-6736(00)04151-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Heart failure in 10 years time: focus on pharmacological treatment.

Authors:  J J V McMurray
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

2.  Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies.

Authors:  E Herpel; S Singer; C Flechtenmacher; M Pritsch; F-U Sack; S Hagl; H A Katus; M Haass; H F Otto; P A Schnabel
Journal:  Virchows Arch       Date:  2005-04-02       Impact factor: 4.064

3.  Bone marrow-derived cells contribute to fibrosis in the chronically failing heart.

Authors:  Po-Yin Chu; Justin Mariani; Samara Finch; Julie R McMullen; Junichi Sadoshima; Tanneale Marshall; David M Kaye
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

Review 4.  ECM remodeling in hypertensive heart disease.

Authors:  Bradford C Berk; Keigi Fujiwara; Stephanie Lehoux
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 5.  Modeling heart failure in animal models for novel drug discovery and development.

Authors:  Paul M L Janssen; Mohammad T Elnakish
Journal:  Expert Opin Drug Discov       Date:  2019-03-12       Impact factor: 6.098
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.